Tru Independence LLC Amgen Inc Transaction History

Tru Independence LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $33,750 - $39,543	-159 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $483,744 - $536,678	-2,071 Reduced 92.87%	159 $39,000
Q1 2021 May 20, 2021	SELL	$221.91 - $258.6 $224,351 - $261,444	-1,011 Reduced 31.19%	2,230 $555,000
Q4 2020 Mar 09, 2021	BUY	$216.38 - $257.67 $37,000 - $44,061	171 Added 5.57%	3,241 $745,000
Q3 2020 Nov 19, 2020	BUY	$234.65 - $260.95 $15,486 - $17,222	66 Added 2.2%	3,070 $780,000
Q2 2020 Aug 19, 2020	BUY	$197.81 - $242.74 $7,121 - $8,738	36 Added 1.21%	3,004 $709,000
Q4 2019 May 19, 2020	BUY	$189.21 - $243.2 $561,575 - $721,817	2,968 New	2,968 $602,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.